{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T20:45:08Z","timestamp":1773693908244,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cytokine"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/j.cyto.2021.155525","type":"journal-article","created":{"date-parts":[[2021,4,23]],"date-time":"2021-04-23T06:53:02Z","timestamp":1619160782000},"page":"155525","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Association of an IFN-\u03b3 variant with susceptibility to chronic hepatitis B by the enhancement of HBV DNA replication"],"prefix":"10.1016","volume":"143","author":[{"given":"Walid","family":"Ben Selma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ahmed Baligh","family":"Laribi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4092-8201","authenticated-orcid":false,"given":"Sana","family":"Alibi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jalel","family":"Boukadida","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.cyto.2021.155525_b0005","unstructured":"WHO | Global Hepatitis Report 2017, Geneva: World Health Organization; 2017. Licence: CC BY-NC-SA 3.0 IGO. p. 8. Available from: <https:\/\/apps.who.int\/iris\/bitstream\/handle\/10665\/255016\/9789241565455-eng.pdf> Accessed October 13, 2020."},{"key":"10.1016\/j.cyto.2021.155525_b0010","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/S0002-9440(10)64980-2","article-title":"Viruses, immunity, and cancer: lessons from hepatitis B","volume":"156","author":"Chisari","year":"2000","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2021.155525_b0015","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1111\/apt.12717","article-title":"Review article: genetic factors that modify the outcome of viral hepatitis","volume":"39","author":"Stattermayer","year":"2014","journal-title":"Aliment Pharmacol. Ther."},{"key":"10.1016\/j.cyto.2021.155525_b0020","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1055\/s-2007-1007107","article-title":"Cytokines in viral hepatitis","volume":"19","author":"Koziel","year":"1999","journal-title":"Semin. Liver Dis."},{"key":"10.1016\/j.cyto.2021.155525_b0025","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/sj.gene.6363733","article-title":"Cytokine gene polymorphism in human disease: On-line databases, supplement 1","volume":"2","author":"Bidwell","year":"2001","journal-title":"Genes Immun."},{"key":"10.1016\/j.cyto.2021.155525_b0030","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.imlet.2020.06.004","article-title":"Interaction analysis of IL-12A and IL-12B gene variants with chronic hepatitis B infection in Tunisian patients","volume":"225","author":"Ben Selma","year":"2020","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cyto.2021.155525_b0035","first-page":"30398","article-title":"IL-18 variant increases risk of enhanced HBV DNA replication in chronic hepatitis","volume":"S0165-2478","author":"Ben Selma","year":"2020","journal-title":"Immunol. Lett."},{"key":"10.1016\/j.cyto.2021.155525_b0040","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1038\/sj.cdd.4400823","article-title":"Host defense, viruses and apoptosis","volume":"2","author":"Barber","year":"2001","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.cyto.2021.155525_b0045","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1189\/jlb.0603252","article-title":"Interferon-gamma: an overview of signals, mechanisms and functions","volume":"75","author":"Schroder","year":"2004","journal-title":"J. Leukoc. Biol."},{"key":"10.1016\/j.cyto.2021.155525_b0050","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1002\/hep.510230103","article-title":"Cytokine inhibition of the hepatitis B virus core promoter","volume":"23","author":"Romero","year":"1996","journal-title":"Hepatology"},{"key":"10.1016\/j.cyto.2021.155525_b0055","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1016\/S0198-8859(00)00167-1","article-title":"A single nucleotide polymorphism in the first intron of the human IFN-gamma gene: absolute correlation with a polymorphic CA microsatellite marker of high IFN-gamma production","volume":"61","author":"Pravica","year":"2000","journal-title":"Human. Immunol."},{"key":"10.1016\/j.cyto.2021.155525_b0060","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.humimm.2009.01.019","article-title":"Combined analysis of interferon-gamma and interleukin-10 gene polymorphisms and chronic hepatitis C severity","volume":"70","author":"Bouzgarrou","year":"2009","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.cyto.2021.155525_b0065","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.cyto.2004.10.013","article-title":"Pro- and anti inflammatory cytokines gene polymorphisms and Helicobacter pylori infection: interactions influence outcome","volume":"29","author":"Zambon","year":"2004","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2021.155525_b0070","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1186\/1471-2334-6-82","article-title":"The interferon gamma gene polymorphism +874 A\/T is associated with severe acute respiratory syndrome","volume":"4","author":"Chong","year":"2006","journal-title":"BMC Infect. Dis."},{"key":"10.1016\/j.cyto.2021.155525_b0075","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1089\/dna.2010.1157","article-title":"Interferon gamma +874T\/A polymorphism is associated with susceptibility to active pulmonary tuberculosis development in Tunisian patients","volume":"30","author":"Ben Selma","year":"2011","journal-title":"DNA Cell Biol."},{"issue":"39","key":"10.1016\/j.cyto.2021.155525_b0080","doi-asserted-by":"crossref","first-page":"5858","DOI":"10.1016\/j.vaccine.2018.08.038","article-title":"Observational study of vaccine effectiveness 20 years after the introduction of universal hepatitis B vaccination in Tunisia","volume":"36","author":"Ben Hadj","year":"2018","journal-title":"Vaccine"},{"key":"10.1016\/j.cyto.2021.155525_b0085","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1167\/iovs.10-5885","article-title":"Association of interferon-gamma, interleukin-10, and tumor necrosis factor-alpha gene polymorphisms with occurrence and severity of Eal\u2019s disease","volume":"52","author":"Sen","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"key":"10.1016\/j.cyto.2021.155525_b0090","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1093\/aje\/kwn359","article-title":"Hardy-Weinberg equilibrium testing of biological ascertainment for Mendelian randomization studies","volume":"169","author":"Rodriguez","year":"2009","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.cyto.2021.155525_b0095","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1164\/rccm.200205-438BC","article-title":"Interferon-gamma and interleukin-10 gene polymorphisms in pulmonary tuberculosis","volume":"167","author":"L\u00f3pez-Maderuelo","year":"2003","journal-title":"Am. J. Respir. Crit. Care Med."},{"key":"10.1016\/j.cyto.2021.155525_b0100","article-title":"Expression profiles of circulating cytokines, chemokines and immune cells in patients with hepatitis B virus infection","volume":"14","author":"Lian","year":"2014","journal-title":"Hepat. Mon."},{"key":"10.1016\/j.cyto.2021.155525_b0105","doi-asserted-by":"crossref","first-page":"6226","DOI":"10.3748\/wjg.v20.i20.6226","article-title":"Relationship between cytokine gene polymorphisms and chronic hepatitis B virus infection","volume":"20","author":"Tuncbilek","year":"2014","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cyto.2021.155525_b0110","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.humimm.2007.11.006","article-title":"Polymorphism of the interferon gamma gene and risk of tuberculosis in a southeastern Chinese population","volume":"69","author":"Ding","year":"2008","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.cyto.2021.155525_b0115","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.humimm.2010.03.008","article-title":"IFNG +874T\/A polymorphism and cytokine plasma levels are associated with susceptibility to Mycobacterium tuberculosis infection and clinical manifestation of tuberculosis","volume":"71","author":"Vallinoto","year":"2010","journal-title":"Hum. Immunol."},{"key":"10.1016\/j.cyto.2021.155525_b0120","doi-asserted-by":"crossref","first-page":"5610","DOI":"10.3748\/wjg.15.5610","article-title":"Polymorphisms of some cytokines and chronic hepatitis B and C virus infection","volume":"15","author":"Gao","year":"2009","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cyto.2021.155525_b0125","doi-asserted-by":"crossref","first-page":"e44","DOI":"10.1016\/j.ijid.2012.08.004","article-title":"An association study of functional polymorphic genes IRF-1, IFNGR-1, and IFN-\u03b3 with disease progression, aspartate aminotransferase, alanine aminotransferase, and viral load in chronic hepatitis B and C","volume":"17","author":"Korachi","year":"2013","journal-title":"Int. J. Infect. Dis."},{"key":"10.1016\/j.cyto.2021.155525_b0130","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1089\/jir.2013.0054","article-title":"Role of proinflammatory cytokines (interferon gamma) and anti-inflammatory cytokine (interleukin-10) gene polymorphisms in chronic hepatitis B infection: an Indian scenario","volume":"34","author":"Srivastava","year":"2014","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.cyto.2021.155525_b0135","doi-asserted-by":"crossref","first-page":"527","DOI":"10.3109\/03014460.2015.1106583","article-title":"Association between IFN-\u03b3 genetic polymorphisms and susceptibility to hepatitis B virus infection: a meta-analysis","volume":"43","author":"Wei","year":"2016","journal-title":"Ann. Hum. Biol."},{"key":"10.1016\/j.cyto.2021.155525_b0140","article-title":"Interferon gamma +874T\/A polymorphism increases the risk of hepatitis virus-related diseases: evidence from a meta-analysis","volume":"10","author":"Sun","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/j.cyto.2021.155525_b0145","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.meegid.2016.06.043","article-title":"Impact of host gene polymorphisms on susceptibility to chronic hepatitis B virus infection","volume":"44","author":"Moudi","year":"2016","journal-title":"Infect. Genet. Evol."},{"key":"10.1016\/j.cyto.2021.155525_b0150","doi-asserted-by":"crossref","first-page":"696","DOI":"10.3389\/fgene.2019.00696","article-title":"Host genetic determinants of hepatitis B virus infection","volume":"10","author":"Zhang","year":"2019","journal-title":"Front Genet."},{"key":"10.1016\/j.cyto.2021.155525_b0155","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1111\/j.1478-3231.2004.0922.x","article-title":"Hepatitis B virus-specific T cell response in chronic hepatitis B patients treated with lamivudine and interferon-alpha","volume":"24","author":"Pontesilli","year":"2004","journal-title":"Liver Int."},{"key":"10.1016\/j.cyto.2021.155525_b0160","doi-asserted-by":"crossref","first-page":"287","DOI":"10.4049\/jimmunol.0902761","article-title":"CD8 (+) T cell control of hepatitis B virus replication: direct comparison between cytolytic and noncytolytic functions","volume":"184","author":"Phillips","year":"2010","journal-title":"J. Immunol."},{"key":"10.1016\/j.cyto.2021.155525_b0165","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.jviromet.2011.12.016","article-title":"Specific expression of human interferon-gamma controls hepatitis B virus replication in vitro in secreting hepatitis B surface antigen hepatocytes","volume":"180","author":"Kan","year":"2012","journal-title":"J. Virol. Methods"},{"key":"10.1016\/j.cyto.2021.155525_b0170","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.ajpath.2012.03.036","article-title":"Suppression of furin by interferon-c and the impact on hepatitis B virus antigen biosynthesis in human hepatocytes","volume":"181","author":"Wu","year":"2012","journal-title":"Am. J. Pathol."},{"key":"10.1016\/j.cyto.2021.155525_b0175","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.tube.2006.10.002","article-title":"Interferon-gamma gene +874T\/A polymorphism is associated with tuberculosis and gamma interferon response","volume":"87","author":"Sallakci","year":"2007","journal-title":"Tuberculosis"},{"key":"10.1016\/j.cyto.2021.155525_b0180","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3748\/wjg.v13.i1.82","article-title":"Pathogenesis of hepatitis B virus infection","volume":"13","author":"Baumert","year":"2007","journal-title":"World J. Gastroenterol."},{"key":"10.1016\/j.cyto.2021.155525_b0185","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cld.2007.08.001","article-title":"The immunology of hepatitis B","volume":"11","author":"Vierling","year":"2007","journal-title":"Clin. Liver Dis."},{"key":"10.1016\/j.cyto.2021.155525_b0190","doi-asserted-by":"crossref","first-page":"343","DOI":"10.4321\/S1130-01082009000500006","article-title":"Cytokines \u2013 their pathogenic and therapeutic role in chronic viral hepatitis","volume":"101","author":"Larrubia","year":"2009","journal-title":"Rev. Esp. Enferm. Dig."},{"key":"10.1016\/j.cyto.2021.155525_b0195","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/j.cyto.2013.01.004","article-title":"Association of cytokine gene polymorphisms and serum concentrations with the outcome of chronic hepatitis B","volume":"61","author":"Conde","year":"2013","journal-title":"Cytokine"},{"key":"10.1016\/j.cyto.2021.155525_b0200","doi-asserted-by":"crossref","first-page":"6145","DOI":"10.3748\/wjg.v16.i48.6145","article-title":"Pegylated interferon a-2b up-regulates specific CD8+ T cells in patients with chronic hepatitis B","volume":"16","author":"Chen","year":"2010","journal-title":"World J. Gastroenterol."},{"issue":"2","key":"10.1016\/j.cyto.2021.155525_b0205","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1007\/s12072-010-9232-0","article-title":"Combined effect of pro- and anti-inflammatory cytokine gene polymorphisms on susceptibility to liver cirrhosis in Tunisian HCV-infected patients","volume":"5","author":"Bouzgarrou","year":"2011","journal-title":"Hepatol. Int."}],"container-title":["Cytokine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621001058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1043466621001058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,19]],"date-time":"2025-10-19T21:01:38Z","timestamp":1760907698000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1043466621001058"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7]]},"references-count":41,"alternative-id":["S1043466621001058"],"URL":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155525","relation":{},"ISSN":["1043-4666"],"issn-type":[{"value":"1043-4666","type":"print"}],"subject":[],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of an IFN-\u03b3 variant with susceptibility to chronic hepatitis B by the enhancement of HBV DNA replication","name":"articletitle","label":"Article Title"},{"value":"Cytokine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.cyto.2021.155525","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"155525"}}